Analgesics - Lebanon | Statista Market Forecast

In Lebanon, the revenue in the Analgesics market is estimated to reach US$22.91m in 2024.
It is projected to experience an annual growth rate of -0.17% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, amounting to US$7.24bn in 2024.
Considering the total population, per person revenues of US$4.39 are anticipated in 2024.
Lebanon's analgesics market is experiencing a surge in demand for natural pain relief remedies.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Lebanon has been experiencing steady growth in recent years.

Customer preferences: Lebanese consumers have shown a growing preference for analgesics as a means of managing pain and discomfort. This can be attributed to several factors, including an aging population, increased awareness and education about the benefits of analgesics, and a higher incidence of chronic conditions that require pain management. Additionally, the convenience and accessibility of over-the-counter analgesics have made them a popular choice among consumers.

Trends in the market: One of the key trends in the Analgesics market in Lebanon is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. This has led to a rise in the popularity of herbal analgesics, which are perceived as being safer and more natural.Another trend in the market is the growing demand for analgesics among athletes and fitness enthusiasts. With the increasing popularity of sports and fitness activities in Lebanon, there is a greater need for pain relief products to manage muscle aches and injuries. This has led to the development of specialized analgesics targeted towards athletes, such as sports creams and gels.

Local special circumstances: Lebanon's healthcare system is characterized by a high level of privatization, with a significant portion of healthcare services being provided by the private sector. This has created a favorable environment for the growth of the Analgesics market, as private pharmacies and drugstores play a key role in the distribution of analgesics to consumers.Additionally, Lebanon has a relatively high prevalence of chronic conditions such as arthritis and back pain, which contribute to the demand for analgesics. The country's aging population also plays a role in driving the growth of the market, as older individuals are more likely to require pain management.

Underlying macroeconomic factors: Lebanon has experienced economic challenges in recent years, including political instability and a high level of public debt. These factors have had a negative impact on the overall economy and consumer purchasing power. However, the Analgesics market has remained resilient, as pain relief is considered a necessity by consumers and is therefore less affected by economic fluctuations.Furthermore, the government has implemented measures to support the pharmaceutical industry, including the promotion of local manufacturing and the reduction of import tariffs on pharmaceutical products. This has created a favorable business environment for both local and international pharmaceutical companies operating in Lebanon.In conclusion, the Analgesics market in Lebanon is driven by customer preferences for pain management, including a growing demand for natural and herbal remedies. The market is also influenced by local special circumstances, such as the privatized healthcare system and the prevalence of chronic conditions. Despite economic challenges, the market has remained resilient due to the essential nature of pain relief products and government support for the pharmaceutical industry.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.